Rightway raises $155m Series E led by Francisco Partners
Thrive Capital and Khosla Ventures returned as Rightway expands AI capabilities in its pharmacy-benefits model.
Technology investment behind pharmacy benefits
Francisco Partners led Rightway’s $155 million Series E, with continued participation from Thrive Capital and Khosla Ventures.
The financing will expand the company’s AI capabilities and the technology powering its pharmacy-benefits service. That development combines software with clinical expertise to help members navigate drug choices and employers manage avoidable pharmacy costs.
Use of funds
Expand AI capabilities and the technology powering the pharmacy benefits model.